Table 4 Cox regression analysis on the risk of surgical treatment of ulnar nerve entrapment in individuals with diabetes.

From: Presurgical management of ulnar nerve entrapment in patients with and without diabetes mellitus

 

Unadjusted

Adjusted

Diabetes

 Type 1

Reference

Reference

 Type 2

1.13 (0.81–1.57)

1.75 (1.07–2.87)

Sex

 Women

 

Reference

 Men

 

1.25 (0.94–1.65)

Age

 18–44

 

Reference

 45–64

 

0.95 (0.61–1.47)

 >  = 65

 

0.73 (0.45–1.19)

Level of care

 Primary

 

Reference

 Specialist

 

8.71 (1.22–62.25)

Retinopathy

 No

 

Reference

 Yes

 

0.98 (0.73–1.32)

Duration of diabetes (years)

 

1.01 (1.00–1.03)

BMI (kg/m2)

 

0.99 (0.96–1.02)

Glycemic control

 Optimal

 

Reference

 Acceptable

 

0.80 (0.58–1.12)

 Poor

 

0.90 (0.63–1.27)

Cretatinine (µmol/l)

 

1.00 (1.00–1.00)

Cholesterol (mmol/L)

 

0.99 (0.86–1.14)

  1. Numbers are prevalence ratios with 95% confidence interval. Glycemic control is defined as optimal (HbA1c ≤ 51.1 mmol/mol), acceptable (HbA1c 51.2–63.7 mmol/mol), and poor (HbA1c > 63.7 mmol/mol).
Back to article page